Vista­gen ac­quires Pherin Phar­ma­ceu­ti­cals for 12.4M shares and 'nom­i­nal' cash

Two psy­chi­atric-based drug de­vel­op­ment com­pa­nies, Vista­gen and Pherin Phar­ma­ceu­ti­cals, are merg­ing in a deal worth 12.4 mil­lion shares and a “nom­i­nal amount” of cash, …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER